DANIEL STEHLI: Open Payments
NPI 1861989345 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$404 in 19 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $23 · 2025 $404
Food & beverage: $404
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 5 | $109 |
| Janssen Pharmaceuticals, Inc | 5 | $103 |
| Otsuka America Pharmaceutical, Inc. | 3 | $73 |
| Vanda Pharmaceuticals Inc. | 2 | $33 |
| Neurocrine BioSciences, Inc. | 1 | $30 |
| Alkermes, Inc. | 1 | $20 |
| Lundbeck LLC | 1 | $19 |
| Teva Pharmaceuticals USA, Inc. | 1 | $17 |
Products named: COBENFY, INVEGA SUSTENNA, ABILIFY ASIMTUFII, INGREZZA, ABILIFY MAINTENA, LYBALVI, REXULTI, FANAPT.
Industry payments across FL — which companies pay providers there.
